欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Conus ammiralis Alpha-conotoxin-like 289 CSB-YP316700CNU
CSB-EP316700CNU
CSB-BP316700CNU
CSB-MP316700CNU
CSB-EP316700CNU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans ATPase GET3 (GET3) CSB-YP316702CZD
CSB-EP316702CZD
CSB-BP316702CZD
CSB-MP316702CZD
CSB-EP316702CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Golgi to ER traffic protein 2 (GET2), partial CSB-YP316703CZE1
CSB-EP316703CZE1
CSB-BP316703CZE1
CSB-MP316703CZE1
CSB-EP316703CZE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Recombination protein RecR (recR) CSB-YP316704FMW
CSB-EP316704FMW
CSB-BP316704FMW
CSB-MP316704FMW
CSB-EP316704FMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (NDUFS7) CSB-YP316705PYX
CSB-EP316705PYX
CSB-BP316705PYX
CSB-MP316705PYX
CSB-EP316705PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4) CSB-YP316706PYX
CSB-EP316706PYX
CSB-BP316706PYX
CSB-MP316706PYX
CSB-EP316706PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombus lapidarius Bombolitin-6 CSB-YP316707BID
CSB-EP316707BID
CSB-BP316707BID
CSB-MP316707BID
CSB-EP316707BID-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis UDP-3-O-acylglucosamine N-acyltransferase (lpxD) CSB-YP316708DSB
CSB-EP316708DSB
CSB-BP316708DSB
CSB-MP316708DSB
CSB-EP316708DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Overexpressed in colon carcinoma 1 protein homolog CSB-YP316709RA
CSB-EP316709RA
CSB-BP316709RA
CSB-MP316709RA
CSB-EP316709RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis 30S ribosomal protein S13 (rpsM) CSB-YP316710DSB
CSB-EP316710DSB
CSB-BP316710DSB
CSB-MP316710DSB
CSB-EP316710DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP316711DSB
CSB-EP316711DSB
CSB-BP316711DSB
CSB-MP316711DSB
CSB-EP316711DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Virulence plasmid integrase pGP8-D CSB-YP316712DSA
CSB-EP316712DSA
CSB-BP316712DSA
CSB-MP316712DSA
CSB-EP316712DSA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus miles Alpha-conotoxin-like Ml20.3 CSB-YP316713DWE
CSB-EP316713DWE
CSB-BP316713DWE
CSB-MP316713DWE
CSB-EP316713DWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus rattus Alpha-conotoxin-like Rt20.2 CSB-YP316714CPE
CSB-EP316714CPE
CSB-BP316714CPE
CSB-MP316714CPE
CSB-EP316714CPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Heme-responsive zinc finger transcription factor HAP1 (HAP1), partial CSB-YP316715SVG
CSB-EP316715SVG
CSB-BP316715SVG
CSB-MP316715SVG
CSB-EP316715SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Transposase insH for insertion sequence element IS5A (insH1) CSB-YP316716ENV
CSB-EP316716ENV
CSB-BP316716ENV
CSB-MP316716ENV
CSB-EP316716ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Transposase insH for insertion sequence element IS5I (insH7) CSB-YP316717ENV
CSB-EP316717ENV
CSB-BP316717ENV
CSB-MP316717ENV
CSB-EP316717ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Transposase insH for insertion sequence element IS5-15 (JW5928) CSB-YP316718ENV
CSB-EP316718ENV
CSB-BP316718ENV
CSB-MP316718ENV
CSB-EP316718ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Uncharacterized protein Os02g0798400 (Os02g0798400, LOC_Os02g55500) CSB-YP316719OFG
CSB-EP316719OFG
CSB-BP316719OFG
CSB-MP316719OFG
CSB-EP316719OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus stercusmuscarum Kappa-conotoxin-like SmIVB CSB-YP316720CPG
CSB-EP316720CPG
CSB-BP316720CPG
CSB-MP316720CPG
CSB-EP316720CPG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×